Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Structural Data Showing the Existence of LDI Bonds between the Rings of Dimeric Cofacial Siloxysilicon Phthalocyanines.

Sturtz BW, Moore CE, Jenkins TS, Miller JL, Momberger CD, Rheingold AL, Kenney ME.

J Phys Chem A. 2019 Jan 17;123(2):471-481. doi: 10.1021/acs.jpca.8b09247. Epub 2019 Jan 4.

PMID:
30571117
2.

Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen.

Wang X, Tsui B, Ramamurthy G, Zhang P, Meyers J, Kenney ME, Kiechle J, Ponsky L, Basilion JP.

Mol Cancer Ther. 2016 Aug;15(8):1834-44. doi: 10.1158/1535-7163.MCT-15-0722. Epub 2016 Jun 13.

3.

Dual Receptor-Targeted Theranostic Nanoparticles for Localized Delivery and Activation of Photodynamic Therapy Drug in Glioblastomas.

Dixit S, Miller K, Zhu Y, McKinnon E, Novak T, Kenney ME, Broome AM.

Mol Pharm. 2015 Sep 8;12(9):3250-60. doi: 10.1021/acs.molpharmaceut.5b00216. Epub 2015 Aug 24.

4.

Peptide-Targeted Gold Nanoparticles for Photodynamic Therapy of Brain Cancer.

Meyers JD, Cheng Y, Broome AM, Agnes RS, Schluchter MD, Margevicius S, Wang X, Kenney ME, Burda C, Basilion JP.

Part Part Syst Charact. 2015 Apr;32(4):448-457.

5.

Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.

Dixit S, Novak T, Miller K, Zhu Y, Kenney ME, Broome AM.

Nanoscale. 2015 Feb 7;7(5):1782-90. doi: 10.1039/c4nr04853a.

6.

Synthesis, properties and drug potential of the photosensitive alkyl- and alkylsiloxy-ligated silicon phthalocyanine Pc 227.

Li J, Yang Y, Zhang P, Sounik JR, Kenney ME.

Photochem Photobiol Sci. 2014 Dec;13(12):1690-8. doi: 10.1039/c4pp00321g. Epub 2014 Oct 13.

PMID:
25308695
8.

Long directional interactions (LDIs) in oligomeric cofacial silicon phthalocyanines and other oligomeric and polymeric cofacial phthalocyanines.

Yang Y, Kennedy VO, Updegraph JB 3rd, Samas B, Macikenas D, Chaloux B, Miller JA, Van Goethem EM, Kenney ME.

J Phys Chem A. 2012 Aug 30;116(34):8718-30. doi: 10.1021/jp3025182. Epub 2012 Aug 17.

PMID:
22856506
9.

Long, directional interactions in cofacial silicon phthalocyanine oligomers.

Yang Y, Samas B, Kennedy VO, Macikenas D, Chaloux BL, Miller JA, Speer RL Jr, Protasiewicz J, Pinkerton AA, Kenney ME.

J Phys Chem A. 2011 Nov 17;115(45):12474-85. doi: 10.1021/jp2019445. Epub 2011 Aug 1.

PMID:
21805980
10.

Addressing brain tumors with targeted gold nanoparticles: a new gold standard for hydrophobic drug delivery?

Cheng Y, Meyers JD, Agnes RS, Doane TL, Kenney ME, Broome AM, Burda C, Basilion JP.

Small. 2011 Aug 22;7(16):2301-6. doi: 10.1002/smll.201100628. Epub 2011 Jun 1.

11.

Successful cutaneous delivery of the photosensitizer silicon phthalocyanine 4 for photodynamic therapy.

Lam M, Hsia AH, Liu Y, Guo M, Swick AR, Berlin JC, McCormick TS, Kenney ME, Oleinick NL, Cooper KD, Baron ED.

Clin Exp Dermatol. 2011 Aug;36(6):645-51. doi: 10.1111/j.1365-2230.2010.03989.x. Epub 2011 May 30. Review.

12.

Deep penetration of a PDT drug into tumors by noncovalent drug-gold nanoparticle conjugates.

Cheng Y, Meyers JD, Broome AM, Kenney ME, Basilion JP, Burda C.

J Am Chem Soc. 2011 Mar 2;133(8):2583-91. doi: 10.1021/ja108846h. Epub 2011 Feb 4.

13.

Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers.

Kinsella TJ, Baron ED, Colussi VC, Cooper KD, Hoppel CL, Ingalls ST, Kenney ME, Li X, Oleinick NL, Stevens SR, Remick SC.

Front Oncol. 2011 Jun 30;1:14. doi: 10.3389/fonc.2011.00014. eCollection 2011.

14.

Near-infrared-emitting phthalocyanines. A combined experimental and density functional theory study of the structural, optical, and photophysical properties of Pd(II) and Pt(II) α-butoxyphthalocyanines.

Soldatova AV, Kim J, Rizzoli C, Kenney ME, Rodgers MA, Rosa A, Ricciardi G.

Inorg Chem. 2011 Feb 7;50(3):1135-49. doi: 10.1021/ic102209q. Epub 2010 Dec 28.

PMID:
21188985
15.

Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4.

Rodriguez ME, Kim J, Delos Santos GB, Azizuddin K, Berlin J, Anderson VE, Kenney ME, Oleinick NL.

J Biomed Opt. 2010 Sep-Oct;15(5):051604. doi: 10.1117/1.3484256.

16.

A requirement for bid for induction of apoptosis by photodynamic therapy with a lysosome- but not a mitochondrion-targeted photosensitizer.

Chiu SM, Xue LY, Lam M, Rodriguez ME, Zhang P, Kenney ME, Nieminen AL, Oleinick NL.

Photochem Photobiol. 2010 Sep-Oct;86(5):1161-73. doi: 10.1111/j.1751-1097.2010.00766.x.

17.
18.

Signaling From Lysosomes Enhances Mitochondria-Mediated Photodynamic Therapy In Cancer Cells.

Quiogue G, Saggu S, Hung HI, Kenney ME, Oleinick NL, Lemasters JJ, Nieminen AL.

Proc SPIE Int Soc Opt Eng. 2009 Jul 12;7380(73800C):1-8.

19.

Delivery of the photosensitizer Pc 4 in PEG-PCL micelles for in vitro PDT studies.

Master AM, Rodriguez ME, Kenney ME, Oleinick NL, Gupta AS.

J Pharm Sci. 2010 May;99(5):2386-98. doi: 10.1002/jps.22007.

PMID:
19967780
20.

Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface.

Cheng Y, Samia AC, Li J, Kenney ME, Resnick A, Burda C.

Langmuir. 2010 Feb 16;26(4):2248-55. doi: 10.1021/la902390d.

PMID:
19719162
21.

Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria.

Rodriguez ME, Zhang P, Azizuddin K, Delos Santos GB, Chiu SM, Xue LY, Berlin JC, Peng X, Wu H, Lam M, Nieminen AL, Kenney ME, Oleinick NL.

Photochem Photobiol. 2009 Sep-Oct;85(5):1189-200. doi: 10.1111/j.1751-1097.2009.00558.x. Epub 2009 Apr 6.

22.

Targeting of mitochondria by 10-N-alkyl acridine orange analogues: role of alkyl chain length in determining cellular uptake and localization.

Rodriguez ME, Azizuddin K, Zhang P, Chiu SM, Lam M, Kenney ME, Burda C, Oleinick NL.

Mitochondrion. 2008 Jun;8(3):237-46. doi: 10.1016/j.mito.2008.04.003. Epub 2008 Apr 25.

23.

Photophysical behavior of open-shell first-row transition-metal octabutoxynaphthalocyanines: CoNc(OBu)8 and CuNc(OBu)8 as case studies.

Soldatova AV, Kim J, Rosa A, Ricciardi G, Kenney ME, Rodgers MA.

Inorg Chem. 2008 May 19;47(10):4275-89. doi: 10.1021/ic7023204. Epub 2008 Apr 12.

PMID:
18407627
24.

Oxidative modification of cytochrome c by singlet oxygen.

Kim J, Rodriguez ME, Guo M, Kenney ME, Oleinick NL, Anderson VE.

Free Radic Biol Med. 2008 May 1;44(9):1700-11. doi: 10.1016/j.freeradbiomed.2007.12.031. Epub 2008 Jan 4.

25.

Effect of the functionalization of the axial phthalocyanine ligands on the energy transfer in QD-based donor-acceptor pairs.

Dayal S, Li J, Li YS, Wu H, Samia AC, Kenney ME, Burda C.

Photochem Photobiol. 2008 Jan-Feb;84(1):243-9. doi: 10.1111/j.1751-1097.2007.00227.x.

PMID:
18173727
26.

Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc 4-PDT.

Wang KK, Wilson JD, Kenney ME, Mitra S, Foster TH.

Photochem Photobiol. 2007 Sep-Oct;83(5):1056-62.

PMID:
17880500
27.

Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: the case experience with preclinical mechanistic and early clinical-translational studies.

Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, Oleinick NL.

Toxicol Appl Pharmacol. 2007 Nov 1;224(3):290-9. Epub 2007 Feb 15. Review.

28.

Effects of benzoannulation and alpha-octabutoxy substitution on the photophysical behavior of nickel phthalocyanines: a combined experimental and DFT/TDDFT study.

Soldatova AV, Kim J, Peng X, Rosa A, Ricciardi G, Kenney ME, Rodgers MA.

Inorg Chem. 2007 Mar 19;46(6):2080-93. Epub 2007 Feb 15.

PMID:
17300192
29.

Observation of non-Förster-type energy-transfer behavior in quantum dot-phthalocyanine conjugates.

Dayal S, Lou Y, Samia AC, Berlin JC, Kenney ME, Burda C.

J Am Chem Soc. 2006 Nov 1;128(43):13974-5.

PMID:
17061849
30.

Photophysics of octabutoxy phthalocyaninato-Ni(II) in toluene: ultrafast experiments and DFT/TDDFT studies.

Gunaratne TC, Gusev AV, Peng X, Rosa A, Ricciardi G, Baerends EJ, Rizzoli C, Kenney ME, Rodgers MA.

J Phys Chem A. 2005 Mar 17;109(10):2078-89.

PMID:
16838978
31.

Synthesis and photophysical properties of silicon phthalocyanines with axial siloxy ligands bearing alkylamine termini.

Anula HM, Berlin JC, Wu H, Li YS, Peng X, Kenney ME, Rodgers MA.

J Phys Chem A. 2006 Apr 20;110(15):5215-23.

PMID:
16610845
32.

Pc 4 photodynamic therapy of U87-derived human glioma in the nude rat.

George JE 3rd, Ahmad Y, Varghai D, Li X, Berlin J, Jackowe D, Jungermann M, Wolfe MS, Lilge L, Totonchi A, Morris RL, Peterson A, Lust WD, Kenney ME, Hoppel CL, Sun J, Oleinick NL, Dean D.

Lasers Surg Med. 2005 Jun;36(5):383-9.

PMID:
15965990
33.

Photothermal sensitisation as a novel therapeutic approach for tumours: studies at the cellular and animal level.

Camerin M, Rello S, Villanueva A, Ping X, Kenney ME, Rodgers MA, Jori G.

Eur J Cancer. 2005 May;41(8):1203-12. Epub 2005 Apr 18.

PMID:
15911245
34.

Photothermal sensitisation: evidence for the lack of oxygen effect on the photosensitising activity.

Camerin M, Rodgers MA, Kenney ME, Jori G.

Photochem Photobiol Sci. 2005 Mar;4(3):251-3. Epub 2005 Feb 14.

PMID:
15738991
35.

Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy.

Morris RL, Azizuddin K, Lam M, Berlin J, Nieminen AL, Kenney ME, Samia AC, Burda C, Oleinick NL.

Cancer Res. 2003 Sep 1;63(17):5194-7.

36.

The peripheral benzodiazepine receptor in photodynamic therapy with the phthalocyanine photosensitizer Pc 4.

Morris RL, Varnes ME, Kenney ME, Li YS, Azizuddin K, McEnery MW, Oleinick NL.

Photochem Photobiol. 2002 Jun;75(6):652-61.

PMID:
12081328
37.

Quantification of the selective retention of palladium octabutoxynaphthalocyanine, a potential photothermal drug, in mouse tissues.

Bucking M, Gudgin Dickson EF, Farahani M, Fischer F, Holmes D, Jori G, Kennedy JC, Kenney ME, Peng X, Pottier RH, Weagle G.

J Photochem Photobiol B. 2000 Nov;58(2-3):87-93.

PMID:
11233653
38.

Photothermal sensitization of amelanotic melanoma cells by Ni(II)-octabutoxy-naphthalocyanine.

Busetti A, Soncin M, Reddi E, Rodgers MA, Kenney ME, Jori G.

J Photochem Photobiol B. 1999 Nov-Dec;53(1-3):103-9.

PMID:
10672535
39.

Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts.

Colussi VC, Feyes DK, Mulvihill JW, Li YS, Kenney ME, Elmets CA, Oleinick NL, Mukhtar H.

Photochem Photobiol. 1999 Feb;69(2):236-41.

PMID:
10048316
40.

Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.

Busetti A, Soncin M, Jori G, Kenney ME, Rodgers MA.

Photochem Photobiol. 1998 Sep;68(3):377-81.

PMID:
9747592
41.

Photoinactivation of amelanotic and melanotic melanoma cells sensitized by axially substituted Si-naphthalocyanines.

Soncin M, Busetti A, Biolo R, Jori G, Kwag G, Li YS, Kenney ME, Rodgers MA.

J Photochem Photobiol B. 1998 Mar;42(3):202-10.

PMID:
9595709
42.

A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.

Anderson CY, Freye K, Tubesing KA, Li YS, Kenney ME, Mukhtar H, Elmets CA.

Photochem Photobiol. 1998 Mar;67(3):332-6.

PMID:
9523532
43.

Pharmacokinetic and phototherapeutic properties of axially substituted Si(IV)-tetradibenzobarreleno-octabutoxyphthalocyanines.

Soncin M, Busetti A, Reddi E, Jori G, Rither BD, Kenney ME, Rodgers MA.

J Photochem Photobiol B. 1997 Sep;40(2):163-7.

PMID:
9345784
44.

Structure-activity and mechanism studies on silicon phthalocyanines with Plasmodium falciparum in the dark and under red light.

Zhao XJ, Lustigman S, Li YS, Kenney ME, Ben-Hur E.

Photochem Photobiol. 1997 Aug;66(2):282-7. Erratum in: Photochem Photobiol 1997 Oct;66(4):547.

PMID:
9277150
45.

The synthesis, photophysical and photobiological properties and in vitro structure-activity relationships of a set of silicon phthalocyanine PDT photosensitizers.

He J, Larkin HE, Li YS, Rihter D, Zaidi SI, Rodgers MA, Mukhtar H, Kenney ME, Oleinick NL.

Photochem Photobiol. 1997 Mar;65(3):581-6.

PMID:
9077144
46.

Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice.

Biolo R, Jori G, Soncin M, Rihter B, Kenney ME, Rodgers MA.

Photochem Photobiol. 1996 Feb;63(2):224-8.

PMID:
8657736
47.
48.

High-performance liquid chromatographic determination of the silicon phthalocyanine Pc 4 in human blood.

Zuk MM, Kenney ME, Horowitz B, Ben-Hur E.

J Chromatogr B Biomed Appl. 1995 Nov 17;673(2):320-4.

PMID:
8611969
49.

Inactivation of Trypanosoma cruzi trypomastigote forms in blood components by photodynamic treatment with phthalocyanines.

Gottlieb P, Shen LG, Chimezie E, Bahng S, Kenney ME, Horowitz B, Ben-Hur E.

Photochem Photobiol. 1995 Nov;62(5):869-74.

PMID:
8570725
50.

Photodynamic therapy of ocular melanoma with bis silicon 2,3-naphthalocyanine in a rabbit model.

Hill RA, Reddi S, Kenney ME, Ryan J, Liaw LH, Garrett J, Shirk J, Cheng G, Krasieva T, Berns MW.

Invest Ophthalmol Vis Sci. 1995 Nov;36(12):2476-81.

PMID:
7591637

Supplemental Content

Loading ...
Support Center